Position in RPRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$33,193
+$4,268 QoQ
Shares Held
592
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#545
of 646 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Smithfield Trust Co holds $544,511 across 10 Biotechnology names. RPRX ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503 | $249,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323 | $201,403 | |
| 3 | INCY |
Incyte Corp
|
321 | $36,388 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
592 | $33,193 | |
| 5 | CYTK |
Cytokinetics Inc
|
155 | $13,204 | |
| 6 | TECH |
BIO-TECHNE Corp
|
148 | $10,456 | |
| 7 | KYNB |
Kyntra Bio, Inc.
|
1 | $7 | |
| 8 | MDXG |
Mimedx Group, Inc.
|
606 | $2 |
All Filings in RPRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,193 | 592 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $28,925 | 603 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $23,299 | 603 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $21,520 | 610 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||